Wait. I was told Joe Rogan lies.
Japanese trading and pharmaceutical company Kowa Co Ltd said on Monday anti-parasite drug ivermectin showed an “antiviral effect” against Omicron and other variants of coronavirus in joint non-clinical research.
Kowa did not provide further details. The firm has been working with Kitasato University, a medical university in Tokyo.
Clinical trials evaluating the drug, which is used to treat parasites in animals and humans, are ongoing but promotion of the drug as a COVID-19 treatment has generated controversy here.
The drug is not approved for treatment of COVID-19 in Japan and the U.S. Federal Drug Administration has repeatedly warned against its use.
- Hey, Whatever Happened to Richard Gere? Oh, He Criticized China.
- New Peer-Reviewed Study Shows Ivermectin ‘Significantly’ Reduces COVID Infections, Hospitalization, and Mortality
- Is the Pope Dying? 2022 Conclave?
- Antibody neutralizing all Covid variants found, Chinese scientists claim
- Oh Nooooo. Rock legend Meatloaf dead at 74
- Dr. Zelenko Protocols for America – Live Like you Were Dying
- Inside the January 6th Setup– Who is Ray Epps?
- Sweden’s Lund University researcher faces prosecution for study that showed most rapes are committed by immigrants
- Twitter Eyes Deal With Musk as Soon as Monday
- Tyranny — New infrastructure bill grants U.S. gov’t ability to disable vehicles remotely